Khiron Life Sciences Corp., a recently incorporated Toronto based Ontario company, has raised $2.87 million from 47 investors from Ontario, BC, and foreign jurisdictions including Colombia, Panama, France, Switzerland, Cayman Islands and Austria.
Canaccord Genuity Corp. acted as placement agent.
Khiron Life Sciences Corp, through its wholly-owned subsidiary, Khiron Colombia SAS, is “medically-validated and patient oriented” cannabis provider in Colombia and South America.